ASH 2024 featured practice-changing studies in lymphoid malignancies, including tafasitamab’s impact in FL, ibrutinib’s OS benefit in MCL, and promising epcoritamab data in CLL.

Where do real estate investors stand in the current housing market? Is the net impact of their contributions good or bad?

Joel Harden of the NDP has represented Ottawa Centre since 2018, but is not running again, having been nominated to be a ...